Dr. Agarwal's Health Care Limited has announced a promoter shareholding change through an inter-se transfer between promoter group members. The transaction involves the transfer of equity shares from Dr. Adil Agarwal to Dr. Amar Agarwal by way of gift, executed on December 31, 2025.

Share Transfer Details

The inter-se transfer involved 5,12,473 equity shares, representing 0.16% of the company's total share capital. This transaction was structured as a gift between promoter group members and falls under the regulatory framework of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Shareholding Pattern Changes

Following the transaction, Dr. Amar Agarwal's shareholding in the company has increased from 4.29% to 4.46%. The change reflects an increase of 0.16% in his voting rights and overall stake in the healthcare company, while Dr. Adil Agarwal's shareholding decreased correspondingly.

Company Capital Structure

The company's equity share capital remains unchanged at ₹31.65 crores, consisting of 31,64,70,002 equity shares of Re. 1 each. The total diluted share capital also stands at the same level, indicating no outstanding convertible securities or warrants that could impact the shareholding calculations.

Regulatory Compliance

The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dr. Amar Agarwal submitted the required documentation to both the National Stock Exchange of India Limited and BSE Limited on January 2, 2026, ensuring full regulatory compliance for the inter-se transfer transaction.

The company's shares continue to be listed on both NSE and BSE, with the transfer not affecting the overall promoter group shareholding but only redistributing shares within the promoter group members.

Dr. Agarwal's Health Care Limited has completed the allotment of 3,37,504 equity shares to eligible employees under its Employee Stock Option Scheme 2022. The allotment, approved by the Nomination and Remuneration Committee through a circular resolution dated January 06, 2026, represents the latest exercise of vested stock options by company employees.

Latest ESOP Allotment Details

The recent share allotment was executed at a uniform exercise price, demonstrating the company's continued commitment to employee participation:

The shares have been allotted under the Dr. Agarwal's Health Care Limited - Employee Stock Option Scheme 2022. All allotted equity shares rank pari passu with the existing equity shares of the company, ensuring equal rights and privileges for the holders.

Updated Share Capital Structure

The latest ESOP exercise has resulted in a significant increase in the company's paid-up equity share capital:

The distinctive number range for the newly allotted shares spans from 31,64,70,003 to 31,68,07,506, with the ISIN code INE943P01029 applicable for demat issuance.

Regulatory Compliance and Documentation

The allotment has been conducted in full compliance with Regulation 10(c) of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company filed the required statement under regulation 10(b) with the recognized stock exchanges on February 24, 2025, receiving filing numbers BSE-224564 and NSE-NSE/LIST/47322.

Company Information

Dr. Agarwal's Health Care Limited operates in the healthcare sector and maintains its registered office at 1st Floor, Buhari Towers, No. 4, Moore's Road, Off Greams Road, Near Asan Memorial School, Chennai-600006. The company's shares are listed on both BSE Limited (Scrip Code: 544350) and National Stock Exchange of India Limited (Symbol: AGARWALEYE), providing liquidity and accessibility to investors across major Indian stock exchanges.